2Seventy Bio Inc Focus on bNHL and Solid Tumor Strategy Conference Call Transcript
Thank you for standing by, and welcome to 2seventy bio Research Deep Dive Session 2. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions) I would now like to hand the conference over to your host, Director of Investor Relations, Liz Pingpank. Please go ahead.
Thank you. Thank you. Good afternoon, everyone, and thank you for joining today's session. We're pleased to be joined today by several members of the 2seventy bio team. Our agenda is as follows: Nick and Phil will provide an introduction; and then Mike Certo and Kevin Chin will walk through the bNHL program; Steve Shamah will then discuss our approach in solid tumors; and Susan Abu-Absi will review 2seventy's manufacturing and collaboration before we go to Q&A.
Before I turn it over to Nick, I would like to remind you that we will be making forward-looking statements in today's session, and I encourage you to review our disclosures with the SEC. With that, I'll
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
